| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,944 |
5,172 |
$1.16M |
| G0378 |
Hospital observation service, per hour |
1,940 |
1,467 |
$1.12M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,229 |
6,138 |
$893K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,031 |
1,808 |
$332K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,501 |
7,205 |
$110K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
518 |
406 |
$85K |
| 84484 |
|
7,893 |
4,790 |
$82K |
| 80053 |
Comprehensive metabolic panel |
9,626 |
7,603 |
$71K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,319 |
11,163 |
$63K |
| 71045 |
Radiologic examination, chest; single view |
4,308 |
3,796 |
$52K |
| 87040 |
|
443 |
383 |
$44K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
480 |
414 |
$34K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
478 |
320 |
$26K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
331 |
312 |
$25K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,600 |
1,469 |
$25K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
416 |
386 |
$24K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,084 |
914 |
$24K |
| 87070 |
|
429 |
389 |
$23K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,443 |
4,593 |
$23K |
| 84702 |
|
714 |
582 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
816 |
749 |
$19K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
863 |
671 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
796 |
710 |
$17K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
327 |
309 |
$16K |
| 82962 |
|
4,712 |
1,985 |
$14K |
| 83690 |
|
3,231 |
2,756 |
$12K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,047 |
4,040 |
$12K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
268 |
230 |
$11K |
| 87486 |
|
347 |
317 |
$11K |
| 87581 |
|
331 |
312 |
$11K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
72 |
39 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
246 |
228 |
$8K |
| 82553 |
|
1,376 |
770 |
$8K |
| 81001 |
|
2,672 |
2,375 |
$7K |
| 93971 |
|
44 |
40 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
198 |
189 |
$7K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
375 |
152 |
$7K |
| 93307 |
|
121 |
117 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
156 |
132 |
$5K |
| 90791 |
Psychiatric diagnostic evaluation |
58 |
53 |
$5K |
| 93458 |
|
125 |
121 |
$4K |
| 83880 |
|
533 |
475 |
$4K |
| 82550 |
|
1,580 |
893 |
$4K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
15 |
15 |
$4K |
| 81003 |
|
1,713 |
1,549 |
$3K |
| 87210 |
|
40 |
38 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,701 |
1,024 |
$3K |
| 83605 |
|
310 |
250 |
$3K |
| 85610 |
|
2,940 |
2,630 |
$3K |
| 83735 |
|
1,956 |
1,494 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
357 |
177 |
$2K |
| 86850 |
|
2,037 |
1,881 |
$2K |
| 85730 |
|
2,193 |
2,040 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
180 |
115 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
886 |
723 |
$2K |
| 87088 |
|
292 |
262 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
317 |
288 |
$1K |
| 86900 |
|
2,314 |
1,907 |
$1K |
| 85378 |
|
101 |
97 |
$1K |
| 80061 |
Lipid panel |
310 |
285 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
265 |
242 |
$1K |
| 97161 |
|
13 |
13 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,492 |
1,932 |
$1K |
| 86901 |
|
2,064 |
1,896 |
$1K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
27 |
25 |
$1K |
| 94760 |
|
344 |
217 |
$985.55 |
| C1769 |
Guide wire |
664 |
636 |
$880.46 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
680 |
616 |
$735.58 |
| 82077 |
|
37 |
27 |
$711.02 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,403 |
1,482 |
$675.81 |
| 94664 |
|
145 |
130 |
$672.11 |
| 0223U |
|
54 |
50 |
$639.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
60 |
48 |
$482.33 |
| 87400 |
|
21 |
20 |
$457.74 |
| 81015 |
|
178 |
154 |
$445.40 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
285 |
226 |
$431.84 |
| 85027 |
|
192 |
130 |
$357.40 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
184 |
122 |
$353.47 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
560 |
335 |
$241.90 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
14 |
$226.83 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,876 |
2,511 |
$211.16 |
| 87641 |
|
12 |
12 |
$194.24 |
| J2060 |
Injection, lorazepam, 2 mg |
136 |
97 |
$176.75 |
| J7050 |
Infusion, normal saline solution, 250 cc |
250 |
182 |
$167.45 |
| 84100 |
|
198 |
137 |
$161.12 |
| J2704 |
Injection, propofol, 10 mg |
906 |
821 |
$140.14 |
| 87186 |
|
27 |
25 |
$87.21 |
| 80076 |
|
13 |
12 |
$83.08 |
| 84439 |
|
12 |
12 |
$79.73 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,154 |
2,017 |
$67.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
132 |
125 |
$29.84 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
44 |
27 |
$16.43 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
110 |
97 |
$10.99 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
17 |
14 |
$0.12 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
53 |
51 |
$0.10 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
39 |
38 |
$0.05 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
690 |
658 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
240 |
213 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
19 |
13 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15 |
12 |
$0.00 |
| 84132 |
|
13 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
43 |
41 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
22 |
12 |
$0.00 |